Every month, our
Subscribe here to get updates from the healthcare team in your inbox every day.
Here are the can't-miss stories that our readers loved from the past month:
- The $600 weekly coronavirus unemployment boost is about to end. 3 analysts share predictions for how Congress will replace it, including a special bonus for going back to work.
- Millions of people were getting paid an extra $600 a week on top of their unemployment benefits, thank sto a
coronavirus bailout from March, but that ended in July.
- Millions of people were getting paid an extra $600 a week on top of their unemployment benefits, thank sto a
- The top 20 coronavirus antibody tests ranked by accuracy, and where to find them
- Everything you need to know about the best coronavirus antibody tests.
- 3 reasons why Microsoft is beating out Amazon and Google to become the emerging favorite in healthcare, according to the tech chief of New York's biggest hospital system
- Microsoft's Azure is gaining a bigger foothold in healthcare, because many of Microsoft's other services are compatible with its cloud infrastructure.
- Trump's Medicare chief has a big decision to make over whether doctors should be paid for phone calls and video visits. Here are the 3 biggest concerns she's weighing over the future of healthcare.
- In an exclusive interview with Business Insider, CMS Administrator Seema Verma said it was "crystal clear" that telehealth must continue.
- The 21 billion-dollar startups to watch that are revolutionizing healthcare in 2020
- Healthcare startups are navigating new challenges during the coronavirus pandemic.
- Primary care startup Oak Street is going public. We pored over its 188-page filing, and it reveals 5 crucial details about the company as it looks to transform how seniors are cared for.
- Oak Street contracts with health insurers to provide care to seniors, in particular those who are eligible for both Medicare and Medicaid.
- Morgan Stanley shared a detailed timeline for the top coronavirus vaccine efforts and says we'll know if a shot works by November
- The top vaccine programs all have "a reasonable probability of success" in late-stage clinical trials, analysts at Morgan Stanley said.
- There are more than 160 coronavirus vaccine candidates being developed. Here's how the top drugmakers see the race for a cure playing out in 2020.
- The frontrunners in the race for a vaccine have already produced early human results and are moving into larger trials.
- Moderna's CEO shared a detailed timeline for when we'll know if its coronavirus vaccine works, and cautions that you might not get a shot until the spring
- In a best-case scenario, Moderna's CEO said we could know if his vaccine works in October.
Let us know what you think of our work. What else should we be covering. You can reach me at ztracer@businessinsider.com, or the whole team at healthcare@businessinsider.com.